Literature DB >> 22320298

Nonviral approach for targeted nucleic acid delivery.

M Jafari1, M Soltani, S Naahidi, D N Karunaratne, P Chen.   

Abstract

Despite their relatively lower efficiency, nonviral approaches are emerging as safer alternatives in gene therapy to viral vectors. Delivery of nucleic acids to the target site is an important factor for effective gene expression (plasmid DNA) or knockdown (siRNA) with minimal side effects. Direct deposition at the target site by physical methods, including ultrasound, electroporation and gene gun, is one approach for local delivery. For less accessible sites, the development of carriers that can home into the target tissue is required. Cationic peptides, lipoplexes, polyplexes and nanoplexes have been used as carriers for delivery of nucleic acids. Targeting ligands, such as cell targeting peptides, have also been applied to decorate delivery vehicles in order to enhance their efficacy. This review focuses on delivery strategies and recent progress in non-viral carriers and their modifications to improve their performance in targeting and transfection.

Mesh:

Substances:

Year:  2012        PMID: 22320298     DOI: 10.2174/092986712803414141

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  27 in total

1.  Pathways Governing Polyethylenimine Polyplex Transfection in Microporous Annealed Particle Scaffolds.

Authors:  Norman F Truong; Sasha Cai Lesher-Pérez; Evan Kurt; Tatiana Segura
Journal:  Bioconjug Chem       Date:  2018-12-18       Impact factor: 4.774

2.  Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells.

Authors:  Vivek Badwaik; Linjia Liu; Dinara Gunasekera; Aditya Kulkarni; David H Thompson
Journal:  Mol Pharm       Date:  2016-02-22       Impact factor: 4.939

Review 3.  Targeted polymeric nanoparticles for cancer gene therapy.

Authors:  Jayoung Kim; David R Wilson; Camila G Zamboni; Jordan J Green
Journal:  J Drug Target       Date:  2015-06-10       Impact factor: 5.121

4.  Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle.

Authors:  J P Gomez; C Gonçalves; C Pichon; P Midoux
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

Review 5.  Endocytosis in gene therapy with non-viral vectors.

Authors:  Aritz Perez Ruiz de Garibay
Journal:  Wien Med Wochenschr       Date:  2016-05-03

Review 6.  From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?

Authors:  Giuseppe Fischetto; Stéphane Bermon
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

7.  A Potential Application of Canaloplasty in Glaucoma Gene Therapy.

Authors:  Baohe Tian; Paul L Kaufman
Journal:  Transl Vis Sci Technol       Date:  2013-01-31       Impact factor: 3.283

8.  Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines.

Authors:  Charlotte Pollard; Joanna Rejman; Winni De Haes; Bernard Verrier; Ellen Van Gulck; Thomas Naessens; Stefaan De Smedt; Pieter Bogaert; Johan Grooten; Guido Vanham; Stefaan De Koker
Journal:  Mol Ther       Date:  2012-09-25       Impact factor: 11.454

Review 9.  Matrix-based gene delivery for tissue repair.

Authors:  Cynthia Cam; Tatiana Segura
Journal:  Curr Opin Biotechnol       Date:  2013-05-14       Impact factor: 9.740

Review 10.  Cellular Delivery of RNA Nanoparticles.

Authors:  Lorena Parlea; Anu Puri; Wojciech Kasprzak; Eckart Bindewald; Paul Zakrevsky; Emily Satterwhite; Kenya Joseph; Kirill A Afonin; Bruce A Shapiro
Journal:  ACS Comb Sci       Date:  2016-08-26       Impact factor: 3.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.